Verve Therapeutics, Inc. participated as the seller in this Acquisition transaction.
The divestment involved assets in the Healthcare sector.
The sale was completed on 2025-06-17 00:00:00 for a reported consideration of 10000000000.
Generated by AI, original source from - Data is in progress
Found it useful? Spread the word.
Kirkland & Ellis advises Eli Lilly on its $1.3 billion acquisition of Verve Therapeutics, with Paul, Weiss advising Verve Therapeutics. | The Sponsor - The Sponsor
